HSD17B13 and metabolic dysfunction-associated steatotic liver disease: Here, we briefly overview the discovery, tissue distribution, and subcellular localization of HSD17B13 and highlight the important role in promoting the pathogenesis of NAFLD/NASH in both experimental animal models and patients.